Neurological Institute Outcomes
Headache
Episodic Migraine
Outcomes of Treatment in Episodic Migraine Patients (N = 1195)
2022
GAD-7 = Generalized Anxiety Disorder Questionnaire, HIT-6 = Headache Impact Test, PHQ-9 = Patient Health Questionnaire, PROMIS = Patient Reported Outcome Measurement Information System
In 2022, 1195 patients with episodic migraine completed at least 1 questionnaire following treatment. Of the 258 patients who reported HIT-6 scores > 50 at initial evaluation, 38% reported improvement.¹ Of the 677 patients who reported initial PROMIS Global Health more than one half standard deviation below the normative mean,² 84% improved or remained stable. Of the 369 patients who completed the PHQ-9 at 2 visits and reported initial depressive symptoms above the cutoff of ≥ 10 points,³ 43% reported improvement of depressive symptoms on follow-up. Of the 225 patients who reported initial anxiety symptoms above the cutoff of ≥ 10 points,⁴ 52% reported improvement at follow-up.